Nanobiotix S.A. American Depositary Shares (5NRA)
XDUS
Real-time Data
06:00 AM
Day's Range
32.8052 wk Range
7.15Overview - 5NRA - Nanobiotix S.A. American Depositary Shares
Key Statistics
Valuation
Enterprise Value
42.56M
EV / EBITDA
‪-4.81‬
Profitability
Operating Margin
‪-45.75%‬
Return on Assets
‪-35.36%‬
Return on Equity
‪28.36%‬
Ownership
Shares Outstanding
48.38M
Price stats
50-Day Avg
‪33.19‬
200-Day Avg
‪26.81‬
Peers - 5NRA - Nanobiotix S.A. American Depositary Shares
Peer Comparison
Compared with companies in Biotechnology listed on XDUS.
- 5NRAXDUSNanobiotix S.A. American Depositary Shares+77.55%52-week change—P/E (Trailing)—Profit Margin
- 4E2XDUSRelmada Therapeutics Inc.+86.32%52-week change-2.62P/E (Trailing)—Profit Margin
- 3920XDUSSpyre Therapeutics, Inc.+84.37%52-week change-46.21P/E (Trailing)—Profit Margin
- 42ZXDUSRevolution Medicines Inc.+82.81%52-week change-30.12P/E (Trailing)—Profit Margin
- 87EXDUSDianthus Therapeutics Inc.+78.20%52-week change-22.50P/E (Trailing)—Profit Margin
- 5NRXDUSNanobiotix S.A.+77.54%52-week change—P/E (Trailing)—Profit Margin
- 7BGXDUSOncoinvent ASA+75.21%52-week change-0.06P/E (Trailing)—Profit Margin
Profile Summary - 5NRA - Nanobiotix S.A. American Depositary Shares
About
Nanobiotix S.A. is a pioneering biotechnology company focusing on developing innovative solutions for the treatment of cancer through nanomedicine. It primarily seeks to enhance the efficacy of existing radiotherapy methods, offering a higher precision level in targeting cancer cells while minimizing damage to…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
